Produk

Sandoo minangka Ketorolac Trometamol, Olopatadine Hydrochloride, Vancomycin Hydrochloride produsen lan pemasok sing apik ing China. Pabrik kita wis fokus ing API, anti-kanker, intermediet obat antivirus, bahan kimia sing apik, ekspor lan impor aditif panganan luwih saka 10 taun, lan produk kita nutupi kabeh ndonya, kayata Amerika Serikat, Kanada, Inggris. , Prancis, lsp., lan mboko sithik nutupi luwih saka 20 negara ing saindenging jagad.
View as  
 
3,6-dikloro-4-isopropilpiridazin

3,6-dikloro-4-isopropilpiridazin

Jeneng produk: 3,6-dichloro-4-isopropylpyridazine
Formula Molekul: C7H8Cl2N2
Bobot Molekul: 191.06
Nomer Registrasi CAS: 107228-51-3

Waca liyaneKirim Pitakonan
N-Methyl-1,2-benzenediamine dihydrochloride

N-Methyl-1,2-benzenediamine dihydrochloride

Jeneng produk: N-Methyl-1,2-benzenediamine dihydrochloride
Formula Molekul: C7H11ClN2
Bobot molekul: 158.63
Nomer Registry CAS: 25148-68-9

Waca liyaneKirim Pitakonan
(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H-1,2) ,3-triazol-2-yl)

(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H-1,2) ,3-triazol-2-yl)

Jeneng Produk:(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H- 1,2,3-triazol-2-yl)
Formula Molekul: C23H24Cl2N6O2
Bobot Molekul: 487.39
Nomer Registrasi CAS: 1792993-84-0

Waca liyaneKirim Pitakonan
Olutasidenib

Olutasidenib

Jeneng produk: Olutasidenib
Formula Molekul: C18H15ClN4O2
Bobot Molekul;354.79
Nomer Registrasi CAS;1887014-12-1

Waca liyaneKirim Pitakonan
Trophinetids

Trophinetids

Jeneng produk: Trofinetide
Formula Molekul: C13H21N3O6
Bobot Molekul;315.32
Nomer Registri CAS;853400-76-7

Waca liyaneKirim Pitakonan
Daprodustat

Daprodustat

Jeneng produk: Daprodustat
Formula Molekul: C19H27N3O6
Bobot Molekul;393.43
Nomer Registrasi CAS;960539-70-2

Waca liyaneKirim Pitakonan
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept